Pfizer tracks side effects of growth hormone treatment in indian children
NCT ID NCT06587035
Summary
This study is monitoring the safety of Somatrogon, a growth hormone injection treatment for children with growth hormone deficiency in India. Researchers will follow 50 children aged 3 and older for up to 3 years to track any side effects they experience while receiving this treatment during routine medical care. The study doesn't test new treatments but observes children already prescribed Somatrogon to understand its safety profile better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DWARFISM, PITUITARY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Apollo Children's Hospital
RECRUITINGChennai, Tamil Nadu, 600006, India
-
Apollo Speciality Hospital
RECRUITINGMadurai, Tamil Nadu, 625020, India
-
G Kuppuswamy Naidu Memorial Hospital
RECRUITINGCoimbatore, Tamil Nadu, 641037, India
-
Shivajoyti Clinic
RECRUITINGBengaluru, Karnataka, 560008, India
Conditions
Explore the condition pages connected to this study.